Latest filing published 02 Oct 2026 for BeOne Medicines Ltd., €369k. Read the official filing
Chan Henry Lee discloses dealings in BeOne Medicines Ltd. to SEC (Form 4). Between 15 June 2023 and 30 September 2026, the trades on record add up to 49 filings.
Every open-market trade on record is a sale: 23 sales worth €4.7M. The totals do not cover 4 filings with an undisclosed amount. Other entries cover 6 share grants and 20 option exercises. 2026 to date brings no purchases and 11 sales.
The newest entry dates from 2 October 2026: an open-market sale of €369k, in BeOne Medicines Ltd. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 49 declarations